BCL2 and cancer: Since the apoptotic pathway in cancer cells is often inhibited through the upregulation of antiapoptotic proteins, such as Bcl-2, and the underexpression of proapoptotic proteins, such as Bax, the effects of these compounds on the Bax/Bcl2 ratio and caspase 9 levels in HepG2 and MCF-7 were investigated.